Perentesis Lab
Clinical Research

Clinical and Translational Research

 Dr. Perentesis is an active clinical and translational investigator in developmental therapeutics for pediatric cancers, with significant national leadership roles in national cancer research organizations, including:

  • Investigational Drug Steering Committee (IDSC) of the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP): Member of the Steering Committee; Co-Chair, Signal Transduction Agents Task Force
  • Pediatric Developmental Therapeutics/Phase I Consortium: Member, National Steering Committee, currently vice chair of clinical studies ADVL0813 and ADVL0414
  • Children’s Oncology Group (COG): Member, COG Executive Committee; Chair, Acute Myeloid Leukemia Relapse Committee; Member, Myeloid Diseases Steering Group; Vice Chair, Adolescent and Young Adult Cancer Steering Committee; Member, Institutional Performance Monitoring Committee
  • Department of Defense Neurofibromatosis Clinical Therapeutics Consortium: Chair, Malignant Peripheral Nerve Sheath Tumor Translational Therapies Committee

Contact Us

For additional information, please contact: 

John Perentesis, MD, FAAP

Mailing Address:
3333 Burnet Ave, MLC 7015
Cincinnati, OH 45229

Phone: 513-636-8241
Fax: 513-636-3549
Email: john.perentesis@cchmc.org